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Introduction. Accurate blood pressure (BP) measurement is essential to the diagnosis and management of hypertension in patients
with systemic sclerosis (SSc) to help prevent renal and cardiovascular complications. The presence of an auscultatory gap during
manual BP measurement—the temporary disappearance of the Korotkoﬀ sounds during cuﬀ deﬂation—leads to a potentially
important underestimate of systolic BP if undetected. Objectives. Since the presence of an auscultatory gap is frequently associated
with increased vascular stiﬀness, we investigated its presence and correlates in 50 consecutive SSc patients. Methods.F o re a c h
patient, BP was measured sequentially using three diﬀerent approaches performed in the same order. Results. Sixteen of 50 patients
(32%) had an auscultatory gap which if undetected would have resulted in clinically important underestimates of systolic BP in
4 patients. The presence of an auscultatory gap was statistically associated with the presence of antibodies to RNA polymerase
III (P<0.0068) and SSc diagnosis type (P<0.01). Conclusions. Our study demonstrates that auscultatory gaps are relatively
common in SSc and correlate with markers for SSc vasculopathy. If undetected auscultatory gaps may result in clinically important
underestimation of BP. Thus, electronic oscillometric BP may be preferred in SSc patients.
1.Introduction
Blood pressure (BP) has most commonly been measured
manually using aneroid or mercury sphygmomanome-
ters although electronic oscillometric BP measurement is
increasingly used in many oﬃce settings [1, 2]. Accurate
BP measurement is essential to the appropriate diagnosis
and management of hypertension in patients with systemic
sclerosis (SSc) to help prevent both renal and cardiovascular
complications. Current BP monitoring guidelines in SSc are
based on expert opinion. These guidelines have the goal of
preventing not only cardiovascular complications, but also
scleroderma renal crisis (SRC), which is characterized by
increasedvascularpermeability,activationofthecoagulation
cascade, and increased renin secretion and which may lead
to malignant hypertension, acute renal failure, and death.
While most SRC patients have frank hypertension with BP
≥140/90mmHg, a subset has normotensive SRC heralded by
a gradual rise in BP within the prehypertensive range of 120–
139/80–89mmHg [3, 4]. Whether performed manually or
electronically,accuratemeasurementofBPinbothoﬃce and
home settings is of paramount importance to management
of SSc [2].
One particular error in manual BP measurement, the
failure to detect the presence of an auscultatory gap, results
in a falsely low estimate of systolic BP [1, 2, 5]. With an
auscultatory gap, the Korotkoﬀ sounds temporarily become
inaudible between phase 2 and phase 3 for a few to more
than 20mmHg prior to their reappearance. If a manual
BP measurement is performed by auscultation alone, the
auscultatory gap may not be detected, and the true systolic
BP may be seriously underestimated. To avoid missing an2 International Journal of Rheumatology
auscultatory gap, the radial artery should be palpated while
the cuﬀ pressure is rapidly increased to a level of 30mmHg
above the disappearance of the pulse, followed by auscul-
tation for the Korotkoﬀ sounds during slow deﬂation of
cuﬀ pressure at 2-3mmHg/second [2]. Inadequately trained
medical personnel frequently do not use this technique
and may not detect important auscultatory gaps. In one
study, 21% of patients with hypertension in a primary
care clinic had an auscultatory gap on manual BP mea-
surement [5]. The auscultatory gap does not interfere with
BP measurements with electronic oscillometric equipment
whichmeasuresmeanarterial BPwith subsequentautomatic
calculation of estimated systolic and diastolic BP.
The mechanism for an auscultatory gap is uncertain but
mayinpartrelatetoincreasedstiﬀnessofthearterialwall[5].
Patients with connective tissue disease may have increased
arterial stiﬀness [6] and therefore may be at increased risk
to have an auscultatory gap which if undetected could result
in serious underestimation of systolic BP [6]. The presence
of an undetected auscultatory gap would be of special
concern to patients with impending SRC and could lead to
a dangerous delay in their management.
We designed a study to determine the prevalence and
clinical correlates of auscultatory gaps in patients with SSc
seen at the University of Utah SSc center.
2.MaterialsandMethods
The study was accepted by the Institutional Review Board
at the University of Utah (IRB number 00038705). Inclusion
criteria included adult patients (≥18 years) with a diagnosis
of SSc as accepted by the American College of Rheumatology
[7]. Fifty consecutive SSc patients from the University of
Utah SSc Center were recruited and consented at the time
of a routine clinic visit between January 2011 and September
2011. For each patient, BP was measured sequentially using
three diﬀerent approaches performed in the same order.
Prior to the measurements, each patient emptied their
bladderandrestedforﬁveminutesseatedinachairwithback
supported, legs uncrossed, and with their left arm supported
with the cuﬀ at midsternal level. Cuﬀ size was properly
selected according to midarm circumference with bladder
center directly over the brachial artery on a bared arm [2].
No talking was permitted by the patient or examiner during
the measurements.
First,thesameclinicmedicalassistantperformedasingle
manualauscultatorymeasurementusingacalibratedaneroid
manometer and a high-quality Littmann, Cardiology III
stethoscope with short tubing. Without palpating the radial
artery, the cuﬀ was inﬂated to 160–180mmHg and then
deﬂated at a rate of 2-3mmHg/second. The systolic BP was
noted as the ﬁrst of two discrete, tapping Korotkoﬀ sounds
and the diastolic BP as the disappearance of the Korotkoﬀ
sounds.
After a period of ﬁve minutes, the BP measurement was
repeated by the medical assistant using the Omron HEM-
907 device, a validated electronic oscillometric device, which
automatically performs three sequential BP measurements at
one-minute intervals and averages them. Following another
ﬁve-minute interval, a single manual BP measurement was
performed by the author (T. M. Frech) using the same
aneroid manometer and stethoscope as the medical assistant;
TF was blinded to the results of the two prior BP mea-
surement approaches. TF palpated the radial artery, inﬂated
the cuﬀ 30mmHg beyond the disappearance of the radial
pulse, and then deﬂated the cuﬀ at a rate of 2mmHg/second.
The systolic BP was again noted as the ﬁrst of two discrete,
tapping Korotkoﬀ sounds. The presence and magnitude of
any auscultatory gap were noted and recorded.
In order to assess for interobserver agreement, another
author (J. Penord) assessed ten of the SSc patients. JP was
blinded to the results of TF. TF and JP also assessed twelve
consecutive patients presenting to the Internal Medicine
clinic to assess a comparison of auscultatory gap prevalence.
The presence of the following clinical risk factors for
vascular stiﬀness for SSc patients was noted: age, BMI,
presence of proteinuria (trace or greater on urine dip-
stick),estimatedglomerularﬁltrationrate(MDRDformula),
tobacco use, and diabetes mellitus. Additionally, risk factors
for SRC and evidence of organ damage were documented,
including the presence of RNA polymerase III antibodies,
prednisoneuse,pulmonaryarterialhypertension(PAH),and
interstitial lung disease (ILD). Medications that can aﬀect
BP, including current use of nonsteroidal antiinﬂammatory
drugs (NSAIDs), anti-hypertensive agents, and immunosup-
pressive medications were also recorded.
Nonparametric analysisusing the Kruskal-Wallis test was
used to look for statistical relationships between categorical
data such as the presence of an auscultatory gap and possible
arterial stiﬀness variables: age, diabetes mellitus, tobacco
use, and BP medication use. Additionally, potential markers
for more severe SSc vasculopathy-immunosuppressant use,
nonsteroidal anti-inﬂammatory (NSAID) use, RNA poly-
meraseIIIantibody,pulmonaryarterialhypertension(PAH),
and interstitial lung disease (ILD), were examined for a
statistical relationship with the presence of an auscultatory
gap. Correction using the Bonferroni method was used to
adjust the P values for the multiple comparisons performed.
Analyses of variance (ANOVA) were used to examine
the relationship of modiﬁed Rodnan skin score (mRSS) as a
continuous variable with the same arterial stiﬀness variables.
These analyses were performed using R [8].
Intraobserver agreement was used to calculate the num-
ber of patients needed for assessment of prevalence in the
Internal Medicine Clinic and SSc clinic.
3. Results
In our SSc study population, 92% of subjects were female,
87% were white, and 13% were Hispanic. The age range was
27 to 80 years. The mRSS ranged from 4 to 28, with 85%
of patients being in the limited cutaneous SSc subset. There
was evidence of end-organ damage due to SSc (PAH and/or
ILD) in 65% of patients. In this study 89% of patients were
taking one or more antihypertensive agents, most commonly
a calcium channel blocker used to treat their Raynaud’s
phenomenon. An auscultatory gap was heard in 16 patients
for a prevalence of 32% in this study population. The meanInternational Journal of Rheumatology 3
Table 1:Auscultatorygapassociationwithpossiblearterialstiﬀness
and vasculopathy variables in SSc.
Arterial stiﬀness
variable
Kruskal-Wallis
chi-squared P value
Diagnosis type 8.37 0.01∗
Age 26.43 0.43
Tobacco use 0.12 0.73
Diabetes mellitus 0.06 0.81
BP medication 16.32 0.43
NSAID use 0.06 0.81
Immunosuppression 3.00 0.56
RNA polymerase III 7.31 0.01∗
PAH 3.43 0.33
ILD 4.29 0.12
SSc: systemic sclerosis; BP: blood pressure; NSAID: nonsteroidal anti-
inﬂammatory use; PAH: pulmonary arterial hypertension; ILD: interstitial
lung disease; ∗P<0.05.
auscultatory gap in these 16 patients was 6.1mmHg and
ranged from 4mmHg to 12mmHg. In two patients the
recognitionofthisgapreclassiﬁedthemintothehypertensive
range (SBP ≥ 140mmHg). One of these two patients subse-
quently required hospitalization for scleroderma renal crisis.
In two other patients, the auscultatory gap reclassiﬁed the
patients into the upper portion of the prehypertensive range
(systolic BP of 130–139mmHg). Thus, four patients would
have required medication adjustment based on the more
accurate recognition of their true BP.
As presented in Table 1, the presence of an auscultatory
gap was statistically associated with the presence of antibod-
ies to RNA polymerase III antibody (P<0.0068) and diag-
nosis type, as categorized by limited or diﬀuse cutaneous
disease (P<0.01). Other potential arterial stiﬀness or SSc
vasculopathy variables—age, tobacco use, diabetes mellitus,
BP medication use, NSAID use, immunosuppression use,
PAH, and ILD—were not associated with an auscultatory
gap. No patients had proteinuria.
When ANOVA was used to evaluate the relationship of
arterialstiﬀnessvariablestoskinthickness(mRSS),wefound
age (P<0.02), ILD (P<0.0018), presence of a RNA
polymerase III antibody (P<0.00016), and diagnosis type
(P<0.000003) were signiﬁcantly associated. This suggests
that looking for an auscultatory gap may be particularly
important in older SSc patients with increasing skin score or
where RNA polymerase III antibody is present (Figure 1).
When the presence of an auscultatory gap was assessed
in 10 of the SSc patients by a second physician, the inter-
observer agreement was 0.8. The gap was 4–6mmHg in the
patients in which there was discordance between investi-
gators. Additionally, when the presence of an auscultatory
gap was assessed in twelve internal medicine patients, it
was found 10–25% of the time. The clinical correlates of
auscultatory gap in the Internal Medicine patients were not
recorded and are a limitation of this study. The interobserver
agreement was 0.83. The gap was 4mmHg in the patients in
which there was discordance between investigators.
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4. Conclusions
We measured systolic BP by palpation of the radial pulse and
then by auscultation at the brachial artery and detected an
auscultatory gap in 16 out of 50 consecutively examined SSc
patients (32%) in our clinic. In four of the sixteen patients,
the magnitude of the auscultatory gap would have resulted
in a clinically important underestimate of systolic BP had
it remained undetected. Detection of the auscultatory gap
reclassiﬁed two patients as hypertensive with systolic BPs
of 144mmHg and 148mmHg, and two other patients were
reclassiﬁed into the upper portion of the prehypertensive
range with systolic BPs of 132mmHg and 136mmHg
(Table 2). Failure to detect these auscultatory gaps could
have seriously underestimated the risk of these patients to
develop SRC [9]. Unless health care personnel who measure
BP manually in SSc patients are trained to measure systolic
BP ﬁrst by palpation and then by auscultation, clinically
important auscultatory gaps may not be detected and
systolic BP may be seriously underestimated in a signiﬁcant
minority of SSc patients. Since training medical personnel
to accurately measure manual BP is labor intensive and
not always successful, we would recommend that BP in
SSc patients should be routinely measured using validated
electronic oscillometric equipment since estimates of systolic
BP are not aﬀected by the presence of an auscultatory gap.
The presence of an auscultatory gap in our SSc patients
was statistically associated with the presence of RNA poly-
merase III antibody, a known marker for increased risk of
SRC. It has previously been postulated that the auscultatory
gap is a marker of increased vascular stiﬀness [5]. If our
ﬁndings are conﬁrmed in another, larger population of
SSc patients, the auscultatory gap could be evaluated as a
potential readily available clinical marker of risk for SRC.
Skin thickening as measured by the mRSS was correlated
to other possible factors that may contribute to arterial
stiﬀness in this SSc population including age, ILD, presence4 International Journal of Rheumatology
Table 2: Manual blood pressure in SSc patients with auscultatory gap.
Patient Manual BP without radial
pulse occlusion (MA) Manual BP after pause (TF) Manual BP with radial
pulse palpation (TF)
Auscultatory
Gap
1 120/62 118/68 126/62 8
2 130/68 132/72 144/74 12∗∗
3 110/60 112/60 118/62 6
4 104/64 102/68 110/70 8
5 136/64 138/60 148/62 10∗∗
6 114/60 110/54 116/62 6
7 128/80 128/78 136/76 8∗
8 126/68 122/68 132/70 10∗
9 110/70 104/70 112/64 8
10 110/60 108/64 114/72 6
SSc: systemic sclerosis; BP; blood pressure; MA: medical assistant; TF: Tracy Frech; ∗change to prehypertensive; ∗∗change to hypertensive.
of an RNA polymerase III antibody, and diagnosis type. This
suggests that severity of vasculopathy and ﬁbrosis may be a
second important reason to detect an auscultatory gap in
thispatientpopulation.Additionally,ifanauscultatorygapis
found, a more extensive look for internal organ disease may
be warranted.
Our study has some limitations. It is a small study popu-
lation,andsomeofthearterialstiﬀnessandSScvasculopathy
variables studied did not have adequate power to exclude
their association. For example, only three tobacco users
and eight patients with diabetes mellitus were included in
the study. Additionally, the use of BP medication at low
doses for Raynaud’s phenomenon rather than for BP control
challenges our use of BP medication as an arterial stiﬀness
variable. Our study population is primarily Caucasian; thus
o u rd a t am a yn o tb ea b l et ob eg e n e r a l i z e dt oo t h e rr a c e sa n d
ethnicities.
Nonetheless, our study provides important information
on measurement of BP in SSc. An auscultatory gap appears
to be common occurring in up to 32% of SSc patients,
and failure to detect it may result in clinically important
underestimation of systolic BP and missed opportunities
to intervene early in hypertensive patients. Future studies
should validate whether the auscultatory gap in SSc patients
can predict associated internal organ involvement.
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